CA2435121A1 - Histamine receptor antagonists - Google Patents
Histamine receptor antagonists Download PDFInfo
- Publication number
- CA2435121A1 CA2435121A1 CA002435121A CA2435121A CA2435121A1 CA 2435121 A1 CA2435121 A1 CA 2435121A1 CA 002435121 A CA002435121 A CA 002435121A CA 2435121 A CA2435121 A CA 2435121A CA 2435121 A1 CA2435121 A1 CA 2435121A1
- Authority
- CA
- Canada
- Prior art keywords
- histamine
- receptor
- antagonist
- disease
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0101223.6 | 2001-01-17 | ||
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
| PCT/IB2002/000042 WO2002056871A2 (en) | 2001-01-17 | 2002-01-10 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2435121A1 true CA2435121A1 (en) | 2002-07-25 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002435121A Abandoned CA2435121A1 (en) | 2001-01-17 | 2002-01-10 | Histamine receptor antagonists |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (de) |
| JP (1) | JP2004517883A (de) |
| KR (1) | KR20030069216A (de) |
| CN (1) | CN1486178A (de) |
| AP (1) | AP2002002401A0 (de) |
| AR (1) | AR032101A1 (de) |
| BG (1) | BG107834A (de) |
| BR (1) | BR0206502A (de) |
| CA (1) | CA2435121A1 (de) |
| CR (1) | CR6983A (de) |
| CZ (1) | CZ20031853A3 (de) |
| DO (1) | DOP2002000325A (de) |
| EA (1) | EA200300537A1 (de) |
| EC (1) | ECSP034692A (de) |
| EE (1) | EE200300335A (de) |
| GB (1) | GB0101223D0 (de) |
| GT (1) | GT200200003A (de) |
| HU (1) | HUP0302767A2 (de) |
| IL (1) | IL156087A0 (de) |
| IS (1) | IS6818A (de) |
| MA (1) | MA26980A1 (de) |
| MX (1) | MXPA03006408A (de) |
| NO (1) | NO20033223D0 (de) |
| OA (1) | OA12440A (de) |
| PA (1) | PA8537101A1 (de) |
| PL (1) | PL362793A1 (de) |
| SK (1) | SK8572003A3 (de) |
| SV (1) | SV2003000849A (de) |
| TN (1) | TNSN02003A1 (de) |
| WO (1) | WO2002056871A2 (de) |
| ZA (1) | ZA200304180B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| CA2497788A1 (en) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| WO2004066960A2 (en) * | 2003-01-28 | 2004-08-12 | Schering Corporation | Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| PT2858647T (pt) | 2012-06-08 | 2018-10-03 | Sensorion | Inibidores do recetor h4 para tratamento de tinido |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/sk unknown
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Application Discontinuation
- 2002-01-10 CN CNA028036840A patent/CN1486178A/zh active Pending
- 2002-01-10 EP EP02732099A patent/EP1353657A1/de not_active Withdrawn
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/es unknown
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/ja not_active Withdrawn
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/pt not_active IP Right Cessation
- 2002-01-10 PL PL02362793A patent/PL362793A1/xx not_active Application Discontinuation
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/ko not_active Application Discontinuation
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/cs unknown
- 2002-01-10 EE EEP200300335A patent/EE200300335A/xx unknown
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/hu unknown
- 2002-01-10 EA EA200300537A patent/EA200300537A1/ru unknown
- 2002-01-10 IL IL15608702A patent/IL156087A0/xx unknown
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/es unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/es unknown
- 2002-01-16 GT GT200200003A patent/GT200200003A/es unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/es not_active Application Discontinuation
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/fr unknown
- 2002-01-16 AR ARP020100145A patent/AR032101A1/es not_active Application Discontinuation
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/is unknown
- 2003-05-21 BG BG107834A patent/BG107834A/bg unknown
- 2003-05-22 CR CR6983A patent/CR6983A/es not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/fr unknown
- 2003-07-16 NO NO20033223A patent/NO20033223D0/no not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN02003A1 (fr) | 2005-12-23 |
| CR6983A (es) | 2003-11-25 |
| MA26980A1 (fr) | 2004-12-20 |
| SK8572003A3 (en) | 2004-07-07 |
| NO20033223L (no) | 2003-07-16 |
| JP2004517883A (ja) | 2004-06-17 |
| BR0206502A (pt) | 2003-10-21 |
| NO20033223D0 (no) | 2003-07-16 |
| IL156087A0 (en) | 2003-12-23 |
| GB0101223D0 (en) | 2001-02-28 |
| OA12440A (en) | 2006-05-22 |
| EE200300335A (et) | 2003-12-15 |
| DOP2002000325A (es) | 2003-01-31 |
| WO2002056871A2 (en) | 2002-07-25 |
| MXPA03006408A (es) | 2003-10-15 |
| GT200200003A (es) | 2002-08-19 |
| IS6818A (is) | 2003-05-15 |
| AR032101A1 (es) | 2003-10-22 |
| HUP0302767A2 (hu) | 2003-11-28 |
| EP1353657A1 (de) | 2003-10-22 |
| SV2003000849A (es) | 2003-01-13 |
| BG107834A (bg) | 2004-01-30 |
| EA200300537A1 (ru) | 2004-02-26 |
| PL362793A1 (en) | 2004-11-02 |
| PA8537101A1 (es) | 2002-08-29 |
| CN1486178A (zh) | 2004-03-31 |
| AP2002002401A0 (en) | 2002-03-31 |
| ECSP034692A (es) | 2003-08-29 |
| CZ20031853A3 (cs) | 2004-07-14 |
| KR20030069216A (ko) | 2003-08-25 |
| ZA200304180B (en) | 2004-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1784221B (zh) | 影响体重减轻的组合物 | |
| Barnes | The role of anticholinergics in chronic obstructive pulmonary disease | |
| Maesen et al. | Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group | |
| TWI314054B (en) | Novel methods and compositions for alleviating pain | |
| US20020052312A1 (en) | Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists | |
| NO337128B1 (no) | Anvendelse av en kombinasjon av R,R-glykopyrrolat og et langtidsvirkende β2-mimetisk middel for fremstilling av et medikament for behandling av respiratoriske sykdommer og fremgangsmåte for fremstilling av et farmasøytikum | |
| KR20000029975A (ko) | 히스타민수용체길항제의배합물을사용한상부기도알레르기반응의치료 | |
| HUT74949A (en) | Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists | |
| AU731447B2 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
| JP2007505139A (ja) | 診断された呼吸疾患を有する患者もしくは診断未確定の呼吸疾患を有する患者におけるオピオイド鎮痛薬の投与に関連する危険性を減少するための方法および組成 | |
| US20220211674A1 (en) | Thromboxane Receptor Antagonists in AERD/Asthma | |
| US20080299207A1 (en) | Methods and compositions for administration of oxybutynin | |
| CA2435121A1 (en) | Histamine receptor antagonists | |
| US20040138234A1 (en) | Histamine receptor antagonists | |
| AU2002216328A1 (en) | Histamine receptor antagonists | |
| AU2008333220B2 (en) | Mequitazine for treating or preventing pathologies involving histamine H4 receptors | |
| Fassoulaki et al. | Flumazenil reduces the duration of thiopentone but not of propofol anaesthesia in humans | |
| WO2007145874A1 (en) | Anti-nicotine treatment comprising use of three anticholinergic agents | |
| Bauer et al. | Bradykinin modulation of a spinal nociceptive reflex in the rat | |
| JPH1160483A (ja) | Ｔｎｆ産生阻害剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |